Palghar, Maharashtra, June 09, 2025 – Lupin Human Welfare & Research Foundation (Lupin Foundation), the CSR arm of global pharmaceutical leader Lupin Limited (Lupin), in collaboration with the Public Health Department, Government of Maharashtra, flagged off its third mobile medical van (MMV) under the “Lives” program in Palghar district of Maharashtra.

The MMV was flagged off at the Primary Health Centre in Gorhe by Ms. Meghna Sakore-Bordikar, Hon’ble State Minister for Public Health and Family Welfare, Government of Maharashtra, in the presence of Dr. Hemant Vishnu Savara – Member of Parliament, Palghar, Shri Harichandra Bhoye – MLA, Vikramgad & Wada, Shri Rajendra Gavit – MLA, Palghar, Shri Manoj Ranade – Chief Executive Officer, Zilla Parishad Palghar, Shri. Bhausaheb Fatangare, Add. Collector Palghar, Dr. Santosh Chaudhary – District Health Officer, Zilla Parishad Palghar, Mrs. Archana Gowari – Sarpanch, Gorhe, along with Ms. Tushara Shankar – CSR Head, Lupin & LHWRF and Mr. Akash Patel – Site Head, Lupin Tarapur.

Speaking at the event, Ms. Meghna Sakore-Bordikar stated, “The launch of this mobile medical van marks a significant step in our mission to bring quality healthcare to the doorstep of our rural communities. Often, access is an issue for people living in rural areas. Hence, we are very pleased that Lupin is partnering with us on this journey of promoting equitable and accessible healthcare for all. This initiative aims to improve early detection and treatment of non-communicable diseases (NCDs).”

This is the third MMV under the Lives program and will serve two blocks (Jawhar and Wada) covering a population of over 400,000 in Palghar district. The two existing vans in the district serve Palghar and Dahanu blocks and Vikramgad and Talasari blocks.

Ms. Tushara Shankar, Head, CSR – Lupin and LHWRF, emphasized the broader vision of the Lives program, “By deploying mobile medical vans and strengthening local health infrastructure, we aim to ensure early detection, timely treatment, and sustained management of non-communicable diseases. Our collaboration with the Maharashtra Government exemplifies how public-private collaborations can drive meaningful change in rural healthcare.”

Inaugurated in 2023, the Lives program is a joint initiative between the Government of Maharashtra and LHWRF. It aims to detect NCDs early through community-based screening, provide diagnosis via fully equipped MMVs, and manage cases through regular camps and free medication. The program also focuses on building NCD corners at subcentres and conducting village-level awareness drives to foster behavioral change within communities.

The Lives program has made a significant contribution to public health in Maharashtra and Rajasthan, with a focus on cardiovascular and chronic obstructive pulmonary diseases. The program has screened over 192,677 individuals across 673 villages and has conducted more than 1,100 free medical camps, providing complimentary consultations to over 65,000 patients.

About LHWRF
Lupin Human Welfare & Research Foundation (LHWRF) is the social responsibility arm of Lupin Limited, founded by Dr. Desh Bandhu Gupta in 1988. In its journey spanning over three decades, the foundation has impacted more than 2.02 million beneficiaries across 5400 villages in 26 districts, spread across eight states in India. Throughout its journey, the foundation has primarily focused on creating sustainable livelihood opportunities and fostering economic growth in some of the most underdeveloped districts in India. It adopts a family-centered approach and initiates measures to help break the cycle of poverty, thus making a positive impact on the lives and livelihoods of the beneficiaries.

About Lupin
Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.
To know more, visit www.lupin.com or follow us on LinkedIn  https://www.linkedin.com/company/lupin

For further information or queries please contact:

Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications, Lupin
rajalakshmiazariah@lupin.com

Nachiket Sule
Head – Lives Program, LHWRF
nachiketsule@lupin.com